Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Still Wondering?

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jun 26, 2022 3:48pm

272 Views

Post# 34783297

RE:Still Wondering?

It could have been a simple case of submitting the RFP bid and Dr Kellum making one phone call to the CMO and buying group of ARC.

Although something tells me every CMO and senior buyer across the dialysis industry by now knows exactly where Kellum is, and what his Dialco suite of products represents.

if they don't win 60% Of future US dialysis unit contracts over the next decade I'd be surprised

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario